Article
Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.
Personalized medicine - 1 May 2023
Lu Hongyan, Zhang Zhanhao, Wang Yuliang, Wang Li, Yuan Dongya, He Yongjun, Jin Tianbo
Abstract excerpt
Aim: Interindividual and interethnic differences in drug efficacy drive the development and progress of pharmacogenomics and precision medicine. This study was performed to enrich the pharmacogenomic information for the Lisu population from China. Methods: 54 very important pharmacogene variants were selected from PharmGKB and genotyped in 199 Lisu individuals. The genotype distribution data of 26 populations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
